0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lupus"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Rheumatology Board Review. Edition No. 1 - Product Thumbnail Image

Rheumatology Board Review. Edition No. 1

  • Book
  • July 2014
  • 224 Pages
EUR$100USDGBP
EUR$238USDGBP
EUR$159USDGBP
EUR$102USDGBP
EUR$429USDGBP
EUR$266USDGBP
EUR$332USDGBP
EUR$320USDGBP
EUR$318USDGBP
EUR$186USDGBP
EUR$199USDGBP
Loading Indicator

Lupus is an autoimmune disorder that affects the body's immune system, causing inflammation and tissue damage. It is a chronic condition that can affect multiple organs and systems in the body, including the skin, joints, and kidneys. In the context of Allergy and Immunology, Lupus is a major area of research and treatment. Diagnosis and treatment of Lupus is complex and requires a multidisciplinary approach. Treatment options include medications, lifestyle changes, and physical therapy. The Lupus market is a growing area of research and development, with a focus on improving diagnosis and treatment options. Companies are developing new drugs and therapies to improve the quality of life for those living with Lupus. Additionally, research is being conducted to better understand the underlying causes of the disease. Companies in the Lupus market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Show Less Read more